Rolls-Royce falls to huge loss
Aero-engine maker Rolls-Royce recorded a £5.4bn half-year loss as the collapse in air travel wiped out demand for its engines.


Last week Rolls-Royce warned that its future “could be at risk” after it plunged to a record £5.4bn half-year loss, says Simon Foy in The Daily Telegraph. It says the collapse in air travel has crushed demand for its engines. So it has signalled its intention to raise £2bn from asset sales, including its ITP Aero division, which makes turbine blades for jet engines.
Meanwhile, the firm’s chief financial officer, Stephen Daintith, is leaving to join online grocer Ocado. Daintith’s move looks “rational” given the “ugly” short-term outlook, says Nils Pratley in The Guardian. What’s more, Rolls-Royce’s stock has fallen to a near-ten year low while its debt is “rated as junk”.
Still, it shouldn’t panic just yet. Not only can it sell assets, but it also “still has some room to borrow”. So while the firm’s share price remains“hostage to Covid-19 infections”, and shareholders may be forced to contribute in the form of a rights issue, the group is likely to “muddle through”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
An immediate rights issue might be a better option than selling off key assets, says Ed Cropley on Breakingviews. Asset sales may please creditors, but they will leave the company with a “permanent limp”. As far as ITP Aero is concerned, there is unlikely to be a “seller’s market” for an asset whose operating profit slid by more than two-thirds in the last six months. “And in terms of corporate synergies, losing a maker of jet-engine turbines inside a maker of jet engines sounds very unhelpful.” Selling the family silver “only works if you’ve got something else to eat of
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Bargain Britain boasts both value and momentum
Interview Ian Lance, manager of the Temple Bar Investment Trust, tells Andrew Van Sickle that the outlook for UK stocks has improved and healthy long-term returns are in prospect
By Andrew Van Sickle
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine